Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.160
+0.060 (1.46%)
At close: Sep 18, 2024, 4:00 PM
4.110
-0.050 (-1.20%)
Pre-market: Sep 19, 2024, 4:16 AM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $295.81 million as of September 18, 2024. Its market cap has decreased by -84.56% in one year.
Market Cap
295.81M
Enterprise Value
-86.55M
1-Year Change
-84.56%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $762.70M to $295.81M, a decrease of -61.22%. That is a compound annual growth rate of -19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 291.50M | -72.81% |
| Dec 29, 2023 | 1.07B | -6.73% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 176.58% |
| Apr 3, 2020 | 762.70M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Utah Medical Products | 236.55M |
| Zura Bio | 235.96M |
| Alpha Teknova | 234.53M |
| AirSculpt Technologies | 232.10M |
| MacroGenics | 232.07M |
| Cellectis | 229.73M |
| Nanobiotix | 229.27M |
| Omeros | 228.31M |